申请人:Aventis Pharma S.A.
公开号:US06288126B1
公开(公告)日:2001-09-11
A compound having the formula
wherein R5 is an [A]—CH3, —[A]—C(OH)ZZ′ or —[A]—C(O)Z″ grouping where —[A]— is an alkylene, alkenylene or alkynylene radical or a single bond, and Z, Z′ and Z″ are a hydrogen atom or an optionally substituted alkyl, alkenyl, alkynyl or aryl radical; and R1, R2, R3, R4, R6, R7 and R8 are as defined in the description; the use thereof as a drug, pharmaceutical compositions containing same, a preparation method therefor, and intermediates of said method, are disclosed.
一种化合物,其化学式为其中R5为一个[A]-CH3,-[A]-C(OH)ZZ′或-[A]-C(O)Z″基团,其中-[A]-为一个烷基、烯基或炔基基团或一个单键,而Z、Z′和Z″为氢原子或一个可选择取代的烷基、烯基、炔基或芳基基团;以及R1、R2、R3、R4、R6、R7和R8如描述中所定义;公开了该化合物作为药物的用途,含有该化合物的药用组合物,其制备方法以及该方法的中间体。